NIH Advisory Board Warns RFK Jr.'s Vaccine Clinic Risks Trust

The chair of the advisory board overseeing the National Institutes of Health's Clinical Center Research Hospital used six minutes of a routine meeting on Oct. 23, 2026, to warn that Health Secretary Robert F. Kennedy Jr.'s new vaccine injury clinic could damage the hospital's reputation, according to Ars Technica.

What did the board chair say about the clinic?

Board chair Jack Leslie told fellow members that staying silent "would be a failing as an advisory board," Ars Technica reported. He said he has no objection to studying vaccine injuries themselves, calling them "rare, but real," and said patients who believe they were harmed should "be taken seriously." His concern centered on how Kennedy introduced the clinic rather than on the research question itself. "Trust is slow to build and quick to lose," Leslie said, according to the outlet.

What happened at the ribbon-cutting ceremony?

Kennedy made a surprise appearance at the hospital for a ribbon-cutting event launching his vaccine injury clinic, Ars Technica reported. The ceremony featured a panel of people who say they were injured by vaccines, seated behind placards reading "vaccine injured," speaking alongside Kennedy and other senior Trump administration officials. Leslie singled out those signs as the core problem. "Those signs announce the conclusion that the research has not yet reached and that the research exists to test," he said, per the outlet's account of the meeting. He argued that framing does a disservice both to the patients, who "deserve our care and respect and they deserve answers," and to the hospital, long known among patients with rare conditions as the "house of hope."

Does the clinic add new research capacity to the NIH?

No, according to the hospital's own leadership. Jonathan Green, the hospital's CEO, who sat next to Leslie during the meeting, confirmed that "the NIH has conducted research on the safety and efficacy of vaccines for decades in the past, and it ongoes," Ars Technica reported. Kennedy's clinic arrives with no additional funding and no new clinic space, the outlet reported. Green described it instead as a single new "protocol" layered onto an existing unit: the vaccine evaluation center inside the Clinical Center, which Green said "has been in existence for decades."

What review does the protocol still have to clear?

Like any other research protocol at the hospital, Kennedy's vaccine injury clinic must pass scientific and ethical review before it can proceed, Green told the board. As of the Oct. 23 meeting, that review was still underway, according to Ars Technica's reporting — meaning the ribbon-cutting ceremony took place before the underlying research plan had cleared the hospital's own vetting process. Leslie's objection was not to the existence of a review but to the sequencing: a public launch event, complete with labeled patients and cabinet-level officials, ahead of the scientific sign-off that normally precedes any new protocol at the facility.

Timeline

• Ongoing, prior decades: NIH's vaccine evaluation center operates inside the Clinical Center, studying vaccine safety and efficacy, per CEO Jonathan Green.
• Recent weeks: Secretary Kennedy holds a ribbon-cutting ceremony at the hospital for his vaccine injury clinic, featuring patients labeled "vaccine injured" alongside administration officials.
• Oct. 23, 2026: Board chair Jack Leslie publicly rebukes the rollout at a regularly scheduled advisory board meeting, with Green confirming the clinic's protocol is still under scientific and ethical review.

What to watch next

• Whether the hospital's review board approves, modifies, or rejects Kennedy's protocol, and on what timeline.
• Whether HHS adjusts the clinic's framing — including the "vaccine injured" signage — in response to board criticism.
• Whether additional members of the advisory board or NIH leadership comment publicly on the dispute.
• Whether patients referred to the clinic report on their experience once the protocol, if approved, begins enrolling cases.

The dispute unfolds against a broader HHS push under Kennedy to scrutinize vaccine safety more aggressively than prior administrations, a stance he has held for roughly two decades, Leslie noted in his remarks, according to Ars Technica. The outlet's report did not include a response from HHS or Kennedy's office to Leslie's specific criticisms.

For related coverage of federal officials' public commitments, see HTT News's report on Musk's SpaceX stock pledge to kids.